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ABSTRACT: Stereoconvergent cyclocondensation reactions of (R)- or (S)-phenylglycinol with appropriately substituted cyclohex-
anone-based δ-keto esters are the key steps of short synthetic routes to enantiopure 5-, 7-, and 5,7-substituted cis-
decahydroquinolines. The factors governing the stereoselectivity of the cyclocondensation are discussed. The potential of the meth-
odology is illustrated by a protecting-group-free synthesis of the phlegmarine-type Lycopodium alkaloid (–)-cermizine B.  
The decahydroquinoline (DHQ) ring system is present in 
hundreds of naturally occurring biologically active alkaloids, 
isolated not only from plant species but also from amphibians, 
arthropods, and marine organisms.1 The structural and stereo-
chemical diversity of these alkaloids makes them valuable 
targets for the development of unified synthetic strategies2 and 
the validation of multipurpose building blocks. 
In this context, using phenylglycinol-derived tricyclic lac-
tams as chiral scaffolds, we have developed straightforward 
routes for the enantioselective synthesis of 5-, 6-, 8-, 2,5-, and 
6,8-alkyl substituted cis-DHQs,3 including the DHQ alkaloids 
pumiliotoxin C,3a,c lepadins A-D,3f and myrioxazine A.3e  
We report herein the use of a new phenylglycinol-derived 
tricyclic lactam 3 as the key building block for the enantiose-
lective synthesis of cermizine B,4 a member of the small group 
 
 
Figure 1. Representative phlegmarine-type Lycopodium alka-
loids. 
of phlegmarine-type Lycopodium alkaloids,5 which are charac-
terized by a DHQ ring bearing a C-7 methyl substituent and a 
C-5 2-piperidylmethyl-based side chain (Figure 1). We also 
report a joint experimental-computational study carried out to 
understand the factors governing the stereoselectivity of the 
cyclocondensation reactions leading to 3 and related tricyclic 
lactams. 
From a synthetic standpoint, phlegmarine-type alkaloids are 
among the least studied Lycopodium alkaloids, with only a 
limited number of enantioselective syntheses reported so far in 
both the cis-6 and trans- DHQ7 series.8 
Tricyclic lactam 3, bearing the appropriate absolute configu-
ration for the synthesis of (–)-cermizine B, was prepared in a 
stereoconvergent manner as outlined in Scheme 1. The starting 
cyclohexenone-based δ-keto ester 1 was accessible in four 
steps from R-(+)-pulegone in approximately 70% overall yield 
on a multigram scale, as previously reported.9 The InCl3-
catalyzed Sakurai reaction10 of enone 1 with allyltrime-
thylsilane in the presence of trimethylsilyl chloride was highly 
diastereoselective, leading to trans-3,5-disubstituted cyclohex-
anone 211 in nearly quantitative yield as a 1:1 mixture of C-2 
epimers. Finally, heating a benzene solution of the above 
mixture of δ-keto esters and (R)-phenylglycinol in the pres-
ence of AcOH, using a Dean–Stark system, stereoselectively 
gave a single tricyclic cis-fused lactam 3 in 82% yield. This 
process involves the epimerization of the configurationally 
labile sterocenter α to the ketone group.  
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Scheme 1. Preparation of the Key Phenylglycinol-Derived 
Tricyclic Lactam 3 
 
The stereoselectivity of the above cyclocondensation reac-
tion was not unexpected12 and can be rationalized by consider-
ing that the initially formed imines are in equilibrium with the 
corresponding enamines and four diastereoisomeric oxazoli-
dines. The final irreversible lactamization occurs faster from 
oxazolidine A, which allows the ester group to approach the 
nitrogen atom from the less hindered face of the oxazolidine 
ring, anti to the phenyl, leading to cis-fused13 lactam 3. For-
mation of the alternative cis-fused lactam 4, resulting from 
lactamization of oxazolidine B, was not observed. The abso-
lute configuration of 3 was unambiguously established by X-
ray crystallographic analysis.14 
The allyl substituent at C-5 of the DHQ ring was used to ste-
reoselectively assemble the C-5 2-(S)-piperidylmethyl moiety 
characteristic of (–)-cermizine B. A ruthenium catalyzed15 
oxidative cleavage of olefin 3, followed by reaction of the 
resulting aldehyde with the chiral auxiliary (R)-(+)-tert-
butanesulfinamide afforded N-sulfinyl imine 5 in 61% yield16 
(Scheme 2). A subsequent allylation with allylmagnesium 
bromide stereoselectively17 provided sulfinamide 6 as a single 
stereoisomer, which incorporates a newly created stereogenic 
center having the required S-configuration. Cleavage of the 
chiral auxiliary by acid methanolysis, followed by reaction of 
the resulting primary α-branched amine with acryloyl chloride 
gave diene 7, which underwent an RCM reaction to afford 
dihydropyridone 8 in excellent yield. 
The synthesis of (–)-cermizine B was completed by conven-
tional transformations involving catalytic hydrogenation of 8, 
lactam methylation, alane reduction, which brought about the 
reduction of the two lactam carbonyls and the reductive open-
ing of the oxazolidine ring, and final debenzylation by catalyt-
ic hydrogenation of the resulting cis-DHQ 9. Our synthetic 
cermizine B showed NMR data and a sign of specific rotation 
[–16.0 (c 0.29, MeOH); Lit4 –2 (c 0.6, MeOH)] coincident 
with those reported4,18 for the natural product.  
Scheme 2. Enantioselective Synthesis of (–)-Cermizine B 
 
 
At this point we reasoned that a similar reaction sequence 
starting from (S)- instead of (R)-phenylglycinol would provide 
a synthetic entry to (+)-serratezomine E, a phlegmarine-type 
alkaloid with a cis-fusion opposite to that of cermizine B, via 
tricyclic lactam 10 (Scheme 3). However, surprisingly, cy-
clocondensation of δ-keto esters 2 with (S)-phenylglycinol 
gave a nearly equimolecular mixture of diastereoisomeric 
lactams 10 and 11 (45:55 ratio). The irreversible lactamization 
takes place not only from the expected oxazolidine C via a 
chair-like transition state that avoids repulsive interactions 
with the phenyl substituent, but also from D, which suffers 
from such interactions. Both C and D incorporate an axial 
substituent on the cyclohexane ring.19 
 






To understand the effect of the substituents at the C-5 and C-
7 positions (DHQ numbering) in the above cyclocondensation 
reactions, we studied similar reactions from (R)- and (S)-
phenylglycinol and model keto esters 1220 and 16.21 The re-
sults are shown in Schemes 4 and 5. 
 
Scheme 4. Cyclocondensation Reaction of δ-Keto Esters 12 




Scheme 5. Cyclocondensation Reaction of δ-Keto Esters 16 




Similar to the above cyclocondensations from 2, the reaction 
of 12 with (R)-phenylglycinol stereoselectively gave a single 
tricyclic lactam 13, via oxazolidine E, whereas the reaction 
with (S)-phenylglycinol was not stereoselective, affording a 
15:85 mixture of lactams 14 and 15. In contrast, δ-keto ester 
16 led to a single tricyclic lactam 17 by reaction with (S)-
phenylglycinol and afforded a nearly equimolecular mixture of 
lactams 18 and 19 by reaction with (R)-phenylglycinol.  
The stereoselective generation of lactams 13 and 17 can be 
accounted for by considering the easy lactamization of the 
respective oxazolidine intermediates E and H (equatorial 
methyl group and no interactions with the phenyl substituent 
during the ring closure). On the other hand, the formation of 
lactam 15 as the major product in the cyclocondensation of 12 
with (S)-phenylglycinol (14/15 15:85 ratio) simply reflects the 
strong destabilizing interactions of the axial methyl substituent 
in the intermediate oxazolidine F, precursor of 14. In the light 
of this result, the 1:1 ratio for lactams 18 and 19 in the cy-
clocondensation of 16 with (R)-phenylglycinol (Scheme 5) is 
quite striking, suggesting that oxazolidine J suffers from an 
additional destabilizing effect. 
To definitively clarify the influence of the C-5 and C-7 sub-
stituents (DHQ numbering) in the above cyclocondensation 
reactions, we also studied the cyclocondensation δ-keto ester 2 
(1:1 mixture of C-2 epimers) with 2-aminoethanol, a simple β-
amino alcohol lacking the phenyl substituent of the phenyl-
glycinol moiety. A 15:85 mixture of tricyclic lactams 20 and 
21 was obtained in 81% yield (Scheme 6). 
 





A rationale for this result and those of all the above cy-
clocondensations is that, although both oxazolidine intermedi-
ates K and L incorporate an axial methyl or allyl substituent 
on the cyclohexane ring, K also suffers from repulsive gauche 
interactions between the equatorial allyl substituent and the 
propionate chain. This hypothesis is supported by theoretical 
calculations, which confirm that the protonated intermediate 
L·H+, the species from which the cyclization occurs, is indeed 
3.2 Kcal/mol more stable than the analogous K·H+ intermedi-
ate due to the occurrence of such destabilizing interactions.22 
In summary, the stereochemical outcome of the cyclocon-
densations reported herein depends on the repulsive interac-
tions in the intermediate oxazolidines that undergo irreversible 
lactamization. These interactions are mainly caused by i) the 
approach of the ester group to the nitrogen, syn with respect to 
the phenyl substituent, during the lactamization step; ii) the 
presence of axial substituents on the cyclohexane ring; and iii) 
the repulsive gauche interaction between the equatorial C-5 
substituent (DHQ numbering) and the propionate chain. 
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Finally, to further illustrate the synthetic potential of the 
above cyclocondensation reactions leading to substituted tri-
cyclic lactams, enantiopure lactams 13 and 17 were converted 
in excellent yields to the respective 7- and 5-substituted cis-
DHQs 22 and 23 by the two-step sequence depicted in Scheme 
7. 
 





In conclusion, we have developed straightforward routes 
(only three synthetic steps) to enantiopure 5-, 7-, and 5,7-
substituted cis-DHQs by cyclocondensation of stereoisomeric 
mixtures of cyclohexanone-derived δ-keto esters with (R) and 
(S)-phenylglycinol, which acts as a chiral latent form of am-
monia. Understanding the factors that govern the stereoselec-
tivity of these reactions will allow the design of related stere-
ocontrolled cyclocondensation reactions leading to enanti-
opure cis-DHQs with different substitution and stereochemical 
patterns. 
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